InjazAI

Google DeepMind, Meta, and Isomorphic Labs have invested $300 million in the nonprofit Biohub to build AI-powered biological datasets enabling a 'virtual cell' simulation that could accelerate drug discovery.

1 min read

Google, Meta, and Isomorphic Labs Invest $300M in a 'Virtual Cell'

What happened?

FAQ

What is the 'virtual cell' Google and Meta are investing in?

It is an AI-powered computational model that simulates the behavior of biological cells, allowing researchers to test hypotheses and simulate drug responses digitally before lab experiments.

How much is the investment and who is involved?

The investment totals $300 million from Google DeepMind, Meta, and Isomorphic Labs, part of a broader $1.8 billion initiative, according to Reuters.

How can MENA countries benefit from this trend?

Regional research centers and university hospitals can benefit through partnerships on biological datasets, investment in compute infrastructure, and adopting simulation models for drug and chronic disease research.

Does this investment replace lab experiments?

No. Digital simulation aims to accelerate research and cut costs, but it does not replace lab and clinical validation under regulatory frameworks.

Source: The Verge AI

AI-assisted summary of the source above. High-confidence stories publish automatically; others wait for review. Facts that are not in the source are not added.